Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|September 13, 2023
Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy eraHuanhuan Li, Yangzhi Zhao, Tiangang Ma, et al.
Frontiers in Immunology|July 3, 2026
Obinutuzumab versus rituximab-based chemotherapy in high-tumor burden indolent B-cell lymphoma: a real-world comparative studyXin Wan, Dechuan Liu, Haotian Wang, et al.
American Journal of Cancer Research|December 9, 2020
The protective role of short-chain fatty acids acting as signal molecules in chemotherapy- or radiation-induced intestinal inflammationTian Tian, Yangzhi Zhao, Yi Yang, et al.
Frontiers in Oncology|June 24, 2022
Chidamide Maintenance Therapy Following Induction Therapy in Patients With Peripheral T-Cell Lymphoma Who Are Ineligible for Autologous Stem Cell Transplantation: Case Series From ChinaWei Guo, Xingtong Wang, Jia Li, et al.
Iscience|January 16, 2026
Chidamide: Exploration of maintenance therapy for patients with DLBCL with HBV infectionYing Zhang, Haotian Wang, Wei Guo, et al.
American Journal of Cancer Research|September 19, 2022
Improving the prognostic ability of PET/CT SUVmax to identify follicular lymphoma with early treatment failureXin Wan, Wei Guo, Xingtong Wang, et al.
Translational Cancer Research|January 9, 2026
Polyethylene glycol-conjugated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) primary prophylaxis significantly reduces the duration of neutropenia in non-Hodgkin's lymphoma patients treated with chemotherapy: a randomised trial (NCT05834751)Bowen Wang, Luming Cao, Jia Li, et al.
Frontiers in Immunology|January 22, 2026
Autoimmune disease-associated lymphomas: research progress and reviewChengqian Chen, Wei Guo, Yangzhi Zhao, et al.
Frontiers in Chemistry|July 9, 2020
A Micelle Electrolyte Enabled by Fluorinated Ether Additives for Polysulfide Suppression and Li Metal Stabilization in Li-S BatteryYangzhi Zhao, Chen Fang, Guangzhao Zhang, et al.
International Journal of Cancer|April 18, 2026
Efficacy and Safety Profile of a Rituximab, Methotrexate, and Thiotepa-Based Regimen in Newly Diagnosed Primary CNS LymphomaHaotian Wang, Jia Li, Luming Cao, et al.
Pageof 3